Back to Authors

Mateen, Nargis

A5058013596 | I4210146710

Mayo Clinic

Mayo Clinic in Florida

Citations 3

Transesophageal echocardiography: a tool for intraoperative assessment of coronary blood flow

Journal of Surgical Case Reports | January 10, 2023 | Volume: 2023 | Issue: 1 | Pages: No page available

10.1093/jscr/rjac603 | PMID 36636654

Abstract Transesophageal echocardiography (TEE) has become an indispensable part of cardiac surgery, but its potential for assessing coronary anatomy and blood flow remains underutilised. This case report presents a case of acute iatrogenic left main coronary artery obstruction following re-operative aortic valve replacement that was promptly diagnosed by intraoperative TEE and managed successfully by Bentall operation. We also emphasise the technique of TEE for coronary evaluation, its caveats and its clinical application during cardiac surgery.
Accelerated LVAD pump thrombosis in COVID‐19 patient: Case report and mini review

Journal of Cardiac Surgery | November 8, 2022 | Volume: 37 | Issue: 12 | Pages: 5313-5319

10.1111/jocs.17097 | PMID 36345681

Accelerated LVAD Pump Thrombosis in COVID-19 Patient: Case report and Mini review

No container title available | September 30, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.22541/au.166453983.32235498/v1

Coronavirus (COVID-19) infection exposes patients with heart failure to a higher risk of morbidity and mortality. In LVAD patients, one of the key problems that can lead to life-threatening low-flow or pump malfunction due to thrombus development in the inflow cannula, device body, or outflow graft, implicating hemodynamic instability, hemolysis, renal or hepatic failure, or cerebral or peripheral thromboembolism. [Endothelial protein C receptor and thrombomodulin levels are elevated along with procoagulants such as factor VIII, P-selectin, and von Willebrand factor and downregulated along with thrombomodulin as a result of the cytokine storm released by endothelial and immune cells. In general ,](#ref-0013) LVAD thrombosis has been found to occur in 2–13% of adult patients who use current continuous-flow devices. However, LVAD thrombosis due to COVID-19 is underreported and a few cases presented. We present a case of accelerated LVAD outflow thrombosis in the setting of COVID-19 infection with multiorgan failure.